LU83849A1 - Procede de preparation de derives de xanthine - Google Patents
Procede de preparation de derives de xanthine Download PDFInfo
- Publication number
- LU83849A1 LU83849A1 LU83849A LU83849A LU83849A1 LU 83849 A1 LU83849 A1 LU 83849A1 LU 83849 A LU83849 A LU 83849A LU 83849 A LU83849 A LU 83849A LU 83849 A1 LU83849 A1 LU 83849A1
- Authority
- LU
- Luxembourg
- Prior art keywords
- methyl
- xanthine
- pharmacologically
- general formula
- tetrahydrofurylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8041247 | 1980-12-23 | ||
| GB8041247 | 1980-12-23 | ||
| GB8121332 | 1981-07-10 | ||
| GB8121332 | 1981-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LU83849A1 true LU83849A1 (fr) | 1982-05-07 |
Family
ID=26277965
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LU83849A LU83849A1 (fr) | 1980-12-23 | 1981-12-22 | Procede de preparation de derives de xanthine |
Country Status (16)
| Country | Link |
|---|---|
| AR (1) | AR229037A1 (fr) |
| AU (1) | AU7868481A (fr) |
| DE (1) | DE3150550A1 (fr) |
| DK (1) | DK571581A (fr) |
| ES (1) | ES508103A0 (fr) |
| FI (1) | FI814105L (fr) |
| FR (1) | FR2498602A1 (fr) |
| GR (1) | GR76972B (fr) |
| IT (1) | IT1195301B (fr) |
| LU (1) | LU83849A1 (fr) |
| MA (1) | MA19357A1 (fr) |
| NL (1) | NL8105749A (fr) |
| NO (1) | NO814373L (fr) |
| NZ (1) | NZ199340A (fr) |
| PT (1) | PT74190B (fr) |
| SE (1) | SE8107683L (fr) |
-
1981
- 1981-12-11 MA MA19561A patent/MA19357A1/fr unknown
- 1981-12-17 ES ES508103A patent/ES508103A0/es active Granted
- 1981-12-20 AR AR287909A patent/AR229037A1/es active
- 1981-12-21 NZ NZ199340A patent/NZ199340A/en unknown
- 1981-12-21 DE DE19813150550 patent/DE3150550A1/de not_active Withdrawn
- 1981-12-21 NO NO814373A patent/NO814373L/no unknown
- 1981-12-21 FI FI814105A patent/FI814105L/fi not_active Application Discontinuation
- 1981-12-21 SE SE8107683A patent/SE8107683L/xx not_active Application Discontinuation
- 1981-12-21 GR GR66870A patent/GR76972B/el unknown
- 1981-12-21 NL NL8105749A patent/NL8105749A/nl not_active Application Discontinuation
- 1981-12-21 IT IT25728/81A patent/IT1195301B/it active
- 1981-12-21 FR FR8124455A patent/FR2498602A1/fr not_active Withdrawn
- 1981-12-21 AU AU78684/81A patent/AU7868481A/en not_active Abandoned
- 1981-12-22 DK DK571581A patent/DK571581A/da not_active Application Discontinuation
- 1981-12-22 PT PT74190A patent/PT74190B/pt unknown
- 1981-12-22 LU LU83849A patent/LU83849A1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES8304980A1 (es) | 1983-04-01 |
| NO814373L (no) | 1982-06-24 |
| NL8105749A (nl) | 1982-07-16 |
| AU7868481A (en) | 1982-07-01 |
| FI814105L (fi) | 1982-06-24 |
| DE3150550A1 (de) | 1982-08-12 |
| DK571581A (da) | 1982-06-24 |
| NZ199340A (en) | 1984-07-06 |
| GR76972B (fr) | 1984-09-04 |
| ES508103A0 (es) | 1983-04-01 |
| PT74190B (en) | 1983-05-20 |
| FR2498602A1 (fr) | 1982-07-30 |
| SE8107683L (sv) | 1982-06-24 |
| MA19357A1 (fr) | 1982-07-01 |
| PT74190A (en) | 1982-01-01 |
| IT1195301B (it) | 1988-10-12 |
| IT8125728A0 (it) | 1981-12-21 |
| AR229037A1 (es) | 1983-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1319003B1 (fr) | Xanthines, inhibiteurs de la phosphodiesterase de type v | |
| US4515795A (en) | Pharmaceutical compositions | |
| US5223504A (en) | Xanthine compounds and compositions, and methods of using them | |
| DE60101158T2 (de) | 8-chinolinxanthin and 8-isochinolinxanthin derivate als pde 5 inhibitoren | |
| JP2613355B2 (ja) | パーキンソン氏病治療剤 | |
| JP2928386B2 (ja) | うつ病治療剤 | |
| CA2612176C (fr) | Derives de l'acide dihydrothieno[2,3-d]pyrimidine-6-carboxylique en tant qu'inhibiteurs de pde9 | |
| US4576947A (en) | Pharmaceutical compositions | |
| JP2000516223A (ja) | チエノピリミジン類 | |
| JP2000072773A (ja) | プリン誘導体 | |
| JPH054983A (ja) | イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤 | |
| JPH0242079A (ja) | 縮合ピリミジン誘導体およびその製造方法 | |
| JPH09508127A (ja) | 上皮増殖因子受容体ファミリーのチロシンキナーゼを阻害することができる二環式化合物 | |
| JPH0256484A (ja) | 縮合ピリミジン誘導体およびその製造方法 | |
| JP2005516975A (ja) | ８−ヘテロアリールキサンチンアデノシンａ２ｂ受容体アンタゴニスト | |
| CA2344828A1 (fr) | Derives de ¬1,2,4|triazolo¬1,5-c|pyrimidine | |
| HU180219B (en) | Process for producing substituted xantine derivatives and salts | |
| CA2002834C (fr) | Xanthines cycloalkyles | |
| JP5366211B2 (ja) | アルドース還元酵素阻害活性を有する縮合三環化合物 | |
| ZA200201650B (en) | Selective antagonists of A2B adenosine receptors. | |
| US4097482A (en) | 5-O-Cyanobenzyl-4,5,6,7-tetrahydro-thieno 3,2-c!pyridine maleate | |
| GB2091249A (en) | Xanthine derivatives | |
| JP2000501420A (ja) | 新規なトリアゾロプリン類、その調製方法及び医薬組成物としての使用 | |
| US5082845A (en) | Therapeutic xanthine derivatives for the treatment of peptic ulcer disease | |
| LU83849A1 (fr) | Procede de preparation de derives de xanthine |